Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study.

about

Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations.

P2860

Q48563045-A30851BC-4D95-4288-B870-952B2B3BFD27

P2860

Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study.

Item

http://www.wikidata.org/entity/Q40213372

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Conjugate and 23-valent pneumo ...... ndomized clinical trial study.

@en

type

Item

label

Conjugate and 23-valent pneumo ...... ndomized clinical trial study.

@en

prefLabel

Conjugate and 23-valent pneumo ...... ndomized clinical trial study.

@en

P1476

Conjugate and 23-valent pneumo ...... ndomized clinical trial study.

@en

P2093

Amir Bahari

http://www.w3.org/2001/XMLSchema#string

Javad Ghaffari

http://www.w3.org/2001/XMLSchema#string

Mohammad Sadegh Rezai

http://www.w3.org/2001/XMLSchema#string

Mohammadreza Mahdavi

http://www.w3.org/2001/XMLSchema#string

Shahram Ala

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.

Risk of infection and death among post-splenectomy patients.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.

Vaccination of asplenic or hyposplenic adults.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Vaccination coverage and awareness of infectious risks in patients with an absent or dysfunctional spleen in the Netherlands.

Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia.

Comparative evaluation of renal findings in Beta-thalassemia major and intermedia.

Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.

P304

16-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28503278

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

5412244

http://www.w3.org/2001/XMLSchema#string

Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study.

about

P2860

P2860

Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932